Condition
Locally Advanced Cutaneous Squamous Cell Carcinoma
Total Trials
5
Recruiting
0
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
5Total
P 1 (2)
P 2 (3)
Trial Status
Active Not Recruiting3
Not Yet Recruiting2
Clinical Trials (5)
Showing 5 of 5 trials
NCT04349436Phase 1Active Not Recruiting
Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies
NCT06418724Phase 2Not Yet RecruitingPrimary
Neoadjuvant PD-1 Inhibitor and EGFR Inhibitor in Locally Advanced Cutaneous Squamous Cell Carcinoma
NCT07228442Phase 2Not Yet RecruitingPrimary
L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma
NCT05574101Phase 2Active Not Recruiting
A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer
NCT04305795Phase 1Active Not Recruiting
An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors
Showing all 5 trials